SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,901 | -13.8% | 74,485 | +96.8% | 0.00% | 0.0% |
| Q2 2023 | $1,779,330 | +445.2% | 37,842 | +386.5% | 0.00% | – |
| Q1 2023 | $326,364 | -81.3% | 7,778 | -83.0% | 0.00% | -100.0% |
| Q4 2022 | $1,745,705 | +403.1% | 45,771 | +417.0% | 0.00% | – |
| Q3 2022 | $347,000 | -98.8% | 8,854 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $27,958,000 | -19.0% | 844,652 | +4.1% | 0.03% | -14.7% |
| Q4 2021 | $34,518,000 | +32.3% | 811,434 | +37.8% | 0.03% | +21.4% |
| Q3 2021 | $26,100,000 | +11.8% | 589,039 | +43.4% | 0.03% | +12.0% |
| Q2 2021 | $23,335,000 | +24.8% | 410,753 | +64.4% | 0.02% | +8.7% |
| Q1 2021 | $18,704,000 | +29.3% | 249,888 | +49.5% | 0.02% | +21.1% |
| Q4 2020 | $14,461,000 | – | 167,157 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |